Chuan-Yong Guo (Chuanyong Guo)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 36

Top Topics

Epithelial Mesenchymal Transition

Lipopolysaccharide Induced

Top Venues

Journal of cellular and molecular medicine

Journal of experimental & clinical cancer research : CR

Mediators of inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Ji, Ziqi Cheng, Jie Zhang, Jianye Wu, Xuanfu Xu, Chuan-Yong Guo, Jiao Feng
Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway. Journal of cellular and molecular medicine 28 (8) (2024)
Jie Ji, Ziqi Cheng, Jie Zhang, Jianye Wu, Xuanfu Xu, Chuan-Yong Guo, Jiao Feng
Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway. Journal of cellular and molecular medicine 28 (8) (2024)
Jie Ji, Ziqi Cheng, Jie Zhang, Jianye Wu, Xuanfu Xu, Chuan-Yong Guo, Jiao Feng
Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway. Journal of cellular and molecular medicine 28 (8) (2024)
Jie Ji, Ziqi Cheng, Jie Zhang, Jianye Wu, Xuanfu Xu, Chuan-Yong Guo, Jiao Feng
Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway. Journal of cellular and molecular medicine 28 (8) (2024)
Jing-Jing Li, Wei-Qi Dai, Wen-Hui Mo, Wen-Qiang Xu, Yue-Yue Li, Chuan-Yong Guo, Xuan-Fu Xu
Fucoidan Ameliorates Ferroptosis in Ischemia-reperfusion-induced Liver Injury through Nrf2/HO-1/GPX4 Activation. Journal of clinical and translational hepatology 11 (6) (2023)
Jiameng Ding, null WenjuanYang, Yuhui Jiang, Jie Ji, Jie Zhang, Liwei Wu, Jiao Feng, Yuanyuan Zheng, Yan Li, Ziqi Cheng, Qiang Yu, Jianye Wu, Jingjing Li, Kan Chen, Chuan-Yong Guo
Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF- κ B Pathway. Mediators of inflammation 2022 (2022)
Liu Fu, Zhe Wang, Fengxiang Jiang, Guohua Wei, Longe Sun, Chuan-Yong Guo, Jianye Wu, Jianhuan Zhu
High Expression of EIF4G2 Mediated by the TUG1/Hsa-miR-26a-5p Axis Is Associated with Poor Prognosis and Immune Infiltration of Gastric Cancer. Journal of oncology 2022 (2022)
Jiameng Ding, null WenjuanYang, Yuhui Jiang, Jie Ji, Jie Zhang, Liwei Wu, Jiao Feng, Yuanyuan Zheng, Yan Li, Ziqi Cheng, Qiang Yu, Jianye Wu, Jingjing Li, Kan Chen, Chuan-Yong Guo
Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF- κ B Pathway. Mediators of inflammation 2022 (2022)
Jiameng Ding, null WenjuanYang, Yuhui Jiang, Jie Ji, Jie Zhang, Liwei Wu, Jiao Feng, Yuanyuan Zheng, Yan Li, Ziqi Cheng, Qiang Yu, Jianye Wu, Jingjing Li, Kan Chen, Chuan-Yong Guo
Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF- κ B Pathway. Mediators of inflammation 2022 (2022)
Qiang Yu, Weiqi Dai, Jie Ji, Liwei Wu, Jiao Feng, Jingjing Li, Yuanyuan Zheng, Yan Li, Ziqi Cheng, Jie Zhang, Jianye Wu, Xuanfu Xu, Chuan-Yong Guo
Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathway. Journal of cellular and molecular medicine 26 (10) (2022)
Yuhui Jiang, Wenjuan Yang, Jiameng Ding, Jie Ji, Liwei Wu, Yuanyuan Zheng, Yan Li, Ziqi Cheng, Jie Zhang, Qiang Yu, Jiao Feng, Jingjing Li, Jianye Wu, Yingqun Zhou, Chuan-Yong Guo
Luteolin Pretreatment Attenuates Hepatic Ischemia-Reperfusion Injury in Mice by Inhibiting Inflammation, Autophagy, and Apoptosis via the ERK/PPAR α Pathway. PPAR research 2022 (2022)
Jie Ji, Liwei Wu, Jue Wei, Jianye Wu, Chuan-Yong Guo
The Gut Microbiome and Ferroptosis in MAFLD. Journal of clinical and translational hepatology 11 (1) (2022)
Jiameng Ding, null WenjuanYang, Yuhui Jiang, Jie Ji, Jie Zhang, Liwei Wu, Jiao Feng, Yuanyuan Zheng, Yan Li, Ziqi Cheng, Qiang Yu, Jianye Wu, Jingjing Li, Kan Chen, Chuan-Yong Guo
Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF- κ B Pathway. Mediators of inflammation 2022 (2022)
Qiang Yu, Ping Cheng, Jianye Wu, Chuan-Yong Guo
PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis. Journal of cellular and molecular medicine 25 (3) (2021)
Jie Ji, Qiang Yu, Weiqi Dai, Liwei Wu, Jiao Feng, Yuanyuan Zheng, Yan Li, Chuan-Yong Guo
Apigenin Alleviates Liver Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Autophagy via TGF-β1/Smad3 and p38/PPARα Pathways. PPAR research 2021 (2021)
Jie Zhang, Ping Cheng, Weiqi Dai, Jie Ji, Liwei Wu, Jiao Feng, Jianye Wu, Qiang Yu, Jingjing Li, Chuan-Yong Guo
Fenofibrate Ameliorates Hepatic Ischemia/Reperfusion Injury in Mice: Involvements of Apoptosis, Autophagy, and PPAR-α Activation. PPAR research 2021 (2021)
Ya-Ping Xu, Ze-Ning Dong, Si-Wei Wang, Yi-Min Zheng, Chi Zhang, Ying-Qun Zhou, Yu-Jie Zhao, Yan Zhao, Feng Wang, Rui Peng, Mao-Chun Tang, Dou-Sheng Bai, Xiao-Yong Huang, Chuan-Yong Guo
circHMGCS1-016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Yuanyuan Zheng, Yan Li, Jiao Feng, Jingjing Li, Jie Ji, Liwei Wu, Qiang Yu, Weiqi Dai, Jianye Wu, Yingqun Zhou, Chuan-Yong Guo
Cellular based immunotherapy for primary liver cancer. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Yan Li, Yuanyuan Zheng, Liwei Wu, Jingjing Li, Jie Ji, Qiang Yu, Weiqi Dai, Jiao Feng, Jianye Wu, Chuan-Yong Guo
Current status of ctDNA in precision oncology for hepatocellular carcinoma. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Yan Li, Yuanyuan Zheng, Liwei Wu, Jingjing Li, Jie Ji, Qiang Yu, Weiqi Dai, Jiao Feng, Jianye Wu, Chuan-Yong Guo
Correction to: Current status of ctDNA in precision oncology for hepatocellular carcinoma. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Liwei Wu, Qiang Yu, Ping Cheng, Chuan-Yong Guo
PPARγ Plays an Important Role in Acute Hepatic Ischemia-Reperfusion Injury via AMPK/mTOR Pathway. PPAR research 2021 (2021)
Ziqi Cheng, Chuan-Yong Guo
Pemafibrate Pretreatment Attenuates Apoptosis and Autophagy during Hepatic Ischemia-Reperfusion Injury by Modulating JAK2/STAT3β/PPARα Pathway. PPAR research 2021 (2021)
Jingjing Li, Chuan-Yong Guo, Jianye Wu
The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis. Drug design, development and therapy 15 (2021)
Jingjing Li, Chuan-Yong Guo, Jianye Wu
Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent. Drug design, development and therapy 14 (2020)
Jiao Feng, Weiqi Dai, Yuqing Mao, Liwei Wu, Jingjing Li, Kan Chen, Qiang Yu, Rui Kong, Sainan Li, Jie Zhang, Jie Ji, Jianye Wu, Wenhui Mo, Xuanfu Xu, Chuan-Yong Guo
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis. Journal of experimental & clinical cancer research : CR 39 (1) (2020)
Shizan Xu, Yuqing Mao, Jianye Wu, Jiao Feng, Jingjing Li, Liwei Wu, Qiang Yu, Yuting Zhou, Jie Zhang, Jiaojiao Chen, Jie Ji, Kan Chen, Fan Wang, Weiqi Dai, Xiaoming Fan, Chuan-Yong Guo
TGF-β/Smad and JAK/STAT pathways are involved in the anti-fibrotic effects of propylene glycol alginate sodium sulphate on hepatic fibrosis. Journal of cellular and molecular medicine 24 (9) (2020)
Tong Liu, Sainan Li, Liwei Wu, Qiang Yu, Jingjing Li, Jiao Feng, Jie Zhang, Jiaojiao Chen, Yuting Zhou, Jie Ji, Kan Chen, Yuqing Mao, Fan Wang, Weiqi Dai, Xiaoming Fan, Jianye Wu, Chuan-Yong Guo
Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2. Journal of hepatocellular carcinoma 7 (2020)
Liwei Wu, Chuan-Yong Guo, Jianye Wu
Therapeutic potential of PPARγ natural agonists in liver diseases. Journal of cellular and molecular medicine 24 (5) (2020)
Jiao Feng, Jingjing Li, Liwei Wu, Qiang Yu, Jie Ji, Jianye Wu, Weiqi Dai, Chuan-Yong Guo
Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. Journal of experimental & clinical cancer research : CR 39 (1) (2020)
Shihao Xiang, Kan Chen, Ling Xu, Ting Wang, Chuan-Yong Guo
Bergenin Exerts Hepatoprotective Effects by Inhibiting the Release of Inflammatory Factors, Apoptosis and Autophagy via the PPAR-γ Pathway. Drug design, development and therapy 14 (2020)
Yujing Xia, Jingjing Li, Kan Chen, Jiao Feng, Chuan-Yong Guo
Bergenin Attenuates Hepatic Fibrosis by Regulating Autophagy Mediated by the PPAR-γ/TGF-β Pathway. PPAR research 2020 (2020)
Liwei Wu, Wenhui Mo, Jiao Feng, Jingjing Li, Qiang Yu, Sainan Li, Jie Zhang, Kan Chen, Jie Ji, Weiqi Dai, Jianye Wu, Xuanfu Xu, Yuqing Mao, Chuan-Yong Guo
Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathway. British journal of pharmacology 177 (16) (2020)
Qiang Yu, Liwei Wu, Jie Ji, Jiao Feng, Weiqi Dai, Jingjing Li, Jianye Wu, Chuan-Yong Guo
Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 7 (2020)
Jiao Feng, Chengfen Wang, Tong Liu, Jingjing Li, Liwei Wu, Qiang Yu, Sainan Li, Yuting Zhou, Jie Zhang, Jiaojiao Chen, Jie Ji, Kan Chen, Yuqing Mao, Fan Wang, Weiqi Dai, Xiaoming Fan, Jianye Wu, Chuan-Yong Guo
Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis. Journal of cellular and molecular medicine 23 (9) (2019)
Jiao Feng, Liwei Wu, Jie Ji, Kan Chen, Qiang Yu, Jie Zhang, Jiaojiao Chen, Yuqing Mao, Fan Wang, Weiqi Dai, Ling Xu, Jianye Wu, Chuan-Yong Guo
PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma. Journal of experimental & clinical cancer research : CR 38 (1) (2019)
Liwei Wu, Jingjing Li, Tong Liu, Sainan Li, Jiao Feng, Qiang Yu, Jie Zhang, Jiaojiao Chen, Yuting Zhou, Jie Ji, Kan Chen, Yuqing Mao, Fan Wang, Weiqi Dai, Xiaoming Fan, Jianye Wu, Chuan-Yong Guo
Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway. Cancer medicine 8 (10) (2019)